Gayna Whitaker is a passionate advocate for diversity in clinical trials, with a robust background in pharmaceutical marketing and healthcare management, supported by an MBA in the field. With over 25 years of experience in the industry, she is committed to ensuring that clinical research reflects the diverse populations it aims to serve.
In her current role as Director of Site Expansion & Development at AstraZeneca, Gayna leads initiatives focused on enhancing site engagement and fostering partnerships that prioritize inclusive representation in clinical trials. She understands that diversity not only enriches the research process but also improves the validity and applicability of study findings across different demographic groups.
At the Sites Solutions Summit, Gayna will discuss partnerships with new sites to AstraZeneca.
